| agilon health, inc. (AGL) Q1 2025 Earnings Call Transcript |
agilon health, inc. (NYSE:AGL ) Q1 2025 Results Conference Call May 6, 2025 4:30 PM ET Company Participants Evan Smith - Senior Vice President of Investor Relations Steve Sell - Chief Executive Officer Jeff Schwaneke - Chief Financial Officer Conference Call Participants Stephen Baxter - Wells Fargo Elizabeth Anderson - Evercore ISI Jailendra Singh - Truist Securities Justin Lake - Wolfe Research Amir Farahani - Bernstein Lisa Gill - JPMorgan Ryan Langston - TD Cowen Joanna Gajuk - Bank of America Ryan Daniels - William Blair Michael Ha - Baird Matthew Shea - Needham Daniel Grosslight - Citi Jenny Shen - BTIG George Hill - Deutsche Bank Whit Mayo - Leerink Partners Thomas Walsh - Barclays Operator Hello, everybody, and welcome to the agilon health First Quarter 2025 Earnings Conference Call. |
seekingalpha.com |
2025-05-07 00:04:03 |
Czytaj oryginał (ang.) |
| Agilon Health (AGL) Reports Break-Even Earnings for Q1 |
Agilon Health (AGL) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to earnings of $0.01 per share a year ago. |
zacks.com |
2025-05-06 23:10:50 |
Czytaj oryginał (ang.) |
| Bloodied But Unbowed, Agilon Health Can Profit From Improving Market Dynamics |
agilon health's stock has surged over 165% YTD in 2025 despite a 77% decline since its 2021 IPO, driven by CMS rate hikes for 2026. The company faces challenges with significant operating losses and industry headwinds, but remains committed to value-based care over fee-for-service models. agilon's business model involves global capitation fees from health plan payors, focusing on Medicare Advantage through a network of physician partners. |
seekingalpha.com |
2025-04-10 18:39:29 |
Czytaj oryginał (ang.) |
| Agilon (AGL) Moves 26.1% Higher: Will This Strength Last? |
Agilon (AGL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road. |
zacks.com |
2025-04-09 13:55:39 |
Czytaj oryginał (ang.) |
| agilon health to Participate in BofA Securities 2025 Health Care Conference |
WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the BofA Securities 2025 Health Care Conference including a fireside chat presentation on Wednesday, May 14 at 1:00 PM Eastern Time. Interested investors and other parties may listen to a simultaneous webcast of the presentation by visiting the “Events & Presentations” section of agilon health's inve. |
businesswire.com |
2025-04-04 20:15:00 |
Czytaj oryginał (ang.) |
| agilon health Sets Date to Report First Quarter 2025 Financial Results |
WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the first quarter 2025 after the market closes on Tuesday, May 6, 2025, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (404) 975-4839 for international pa. |
businesswire.com |
2025-03-25 18:05:00 |
Czytaj oryginał (ang.) |
| Is Agilon Health (AGL) Stock Outpacing Its Medical Peers This Year? |
Here is how Agilon Health (AGL) and Paragon 28, Inc. (FNA) have performed compared to their sector so far this year. |
zacks.com |
2025-03-20 12:41:31 |
Czytaj oryginał (ang.) |
| Agilon Health Adjusts To Recovery Phase, Analyst Is Cautious On Near-Term Fundamentals |
J.P. Morgan analyst Lisa C. Gill, with a Neutral rating, updated estimates for Agilon Health, Inc. AGL following fourth-quarter results posted last month. |
benzinga.com |
2025-03-18 16:32:10 |
Czytaj oryginał (ang.) |
| Is Agilon Health (AGL) Outperforming Other Medical Stocks This Year? |
Here is how Agilon Health (AGL) and Akero Therapeutics, Inc. (AKRO) have performed compared to their sector so far this year. |
zacks.com |
2025-03-04 12:46:20 |
Czytaj oryginał (ang.) |
| agilon health, inc. (AGL) Q4 2024 Earnings Call Transcript |
agilon health, inc. (NYSE:AGL ) Q4 2024 Earnings Conference Call February 25, 2025 4:30 PM ET Company Participants Evan Smith - Senior Vice President of Investor Relations Steven Sell - Chief Executive Officer Jeffrey Schwaneke - Chief Financial Officer Conference Call Participants Stephen Baxter - Wells Fargo Justin Lake - Wolfe Research Jack Slevin - Jefferies Ryan Langston - TD Cowen Amir Farahani - Bernstein Jailendra Singh - Truist Securities Michael Ha - Baird Elizabeth Anderson - Evercore Adam Ron - Bank of America Ryan Daniels - William Blair Whit Mayo - Leerink Partners Daniel Grosslight - Citi David Larsen - BTIG George Hill - Deutsche Bank Matt Shea - Needham Operator Hello and welcome to the agilon health Fourth Quarter 2024 Earnings Conference. |
seekingalpha.com |
2025-02-26 02:25:06 |
Czytaj oryginał (ang.) |
| Agilon (AGL) Reports Q4 Earnings: What Key Metrics Have to Say |
While the top- and bottom-line numbers for Agilon (AGL) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. |
zacks.com |
2025-02-25 20:30:26 |
Czytaj oryginał (ang.) |
| Agilon Health (AGL) Reports Q4 Loss, Tops Revenue Estimates |
Agilon Health (AGL) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to loss of $0.41 per share a year ago. |
zacks.com |
2025-02-25 20:10:23 |
Czytaj oryginał (ang.) |
| agilon health Reports Fourth Quarter and Full Year Fiscal 2024 Results |
WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the fourth quarter and fiscal year ended December 31, 2024. “While the underlying strength of our model continues to deliver significant value to patients, payors, and our PCP partners, we are still managing through a challenging Medicare Advantage environment.” said Steve Sell, CEO. “As a result of the strategic. |
businesswire.com |
2025-02-25 18:00:00 |
Czytaj oryginał (ang.) |
| agilon health to Participate in TD Cowen's 45th Annual Health Care Conference |
WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health in our communities, announced that it will participate in the 45th Annual TD Cowen Healthcare Conference including a fireside chat presentation on Wednesday, March 5 at 9:50 AM Eastern Time. Interested investors and other parties may listen to a simultaneous webcast of the presentation by visiting the “Events & Presentations” section of agilon health's investor. |
businesswire.com |
2025-02-21 18:00:00 |
Czytaj oryginał (ang.) |
| SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of agilon health, inc. (NYSE: AGL) and Encourages Long-Term Investors to Contact the Firm |
PHILADELPHIA, Feb. 17, 2025 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating agilon health, inc. (NYSE: AGL) on behalf of the company's long-term shareholders. |
globenewswire.com |
2025-02-17 10:30:00 |
Czytaj oryginał (ang.) |
| AGL Energy Limited (AGLNF) Q2 2025 Earnings Conference Call Transcript |
AGL Energy Limited (OTCPK:AGLNF) Q2 2025 Earnings Conference Call February 11, 2025 7:00 PM ET Company Participants Damien Nicks - MD and CEO Gary Brown - CFO Jo Egan - Chief Customer Officer Markus Brokhof - COO Conference Call Participants Tom Allen - UBS Dale Koenders - Barrenjoey Anthony Moulder - Jefferies Rob Koh - Morgan Stanley Gordon Ramsay - RBC Capital Markets Ian Myles - Macquarie Henry Meyer - Goldman Sachs Operator Thank you for standing by, and welcome to the AGL Energy Half Year Results Briefing Conference Call. All participants will be in listen-only mode. |
seekingalpha.com |
2025-02-12 01:20:45 |
Czytaj oryginał (ang.) |
| agilon health Sets Date to Report Fourth Quarter and Full Year 2024 Financial Results |
WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health in our communities, announced that it will release its financial results for the fourth quarter and full year 2024 after the market closes on Tuesday February 25, 2025, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (404) 975-4839 for i. |
businesswire.com |
2025-02-10 18:01:00 |
Czytaj oryginał (ang.) |
| New Strong Sell Stocks for January 28th |
AGL, ASHTY and CCOZY have been added to the Zacks Rank #5 (Strong Sell) List on January 28, 2024. |
zacks.com |
2025-01-28 08:05:21 |
Czytaj oryginał (ang.) |
| New Strong Sell Stocks for January 24th |
WMS, AGL and EADSY have been added to the Zacks Rank #5 (Strong Sell) List on January 24, 2025. |
zacks.com |
2025-01-24 07:01:08 |
Czytaj oryginał (ang.) |
| New Strong Sell Stocks for January 21st |
VLVLY, AGL and APOG have been added to the Zacks Rank #5 (Strong Sell) List on January 21, 2025. |
zacks.com |
2025-01-21 09:21:30 |
Czytaj oryginał (ang.) |
| New Strong Sell Stocks for January 15th |
SKFRY, AGL and ADRZY have been added to the Zacks Rank #5 (Strong Sell) List on January 15, 2025. |
zacks.com |
2025-01-15 08:06:10 |
Czytaj oryginał (ang.) |
| New Strong Sell Stocks for January 10th |
AGL, AEO and AROC have been added to the Zacks Rank #5 (Strong Sell) List on January 10, 2024. |
zacks.com |
2025-01-10 08:56:13 |
Czytaj oryginał (ang.) |
| New Strong Sell Stocks for December 31st |
AGL, AMPH and CR have been added to the Zacks Rank #24 (Strong Sell) List on December 31, 2024. |
zacks.com |
2024-12-31 08:51:19 |
Czytaj oryginał (ang.) |
| New Strong Sell Stocks for December 13th |
AGL, BKGFY and BERY have been added to the Zacks Rank #5 (Strong Sell) List on December 13, 2024. |
zacks.com |
2024-12-13 06:16:09 |
Czytaj oryginał (ang.) |
| New Strong Sell Stocks for December 4th |
ATI, ARLP and AGL have been added to the Zacks Rank #5 (Strong Sell) List on December 4, 2024. |
zacks.com |
2024-12-04 06:35:21 |
Czytaj oryginał (ang.) |
| New Strong Sell Stocks for December 2nd |
ATI, ATS and AGL have been added to the Zacks Rank #5 (Strong Sell) List on December 2, 2024. |
zacks.com |
2024-12-02 07:31:12 |
Czytaj oryginał (ang.) |
| New Strong Sell Stocks for November 19th |
AGL, AFLYY and BATRK have been added to the Zacks Rank #5 (Strong Sell) List on November 19, 2024. |
zacks.com |
2024-11-19 07:00:29 |
Czytaj oryginał (ang.) |
| New Strong Sell Stocks for November 13th |
AOS, AGL and ABG have been added to the Zacks Rank #5 (Strong Sell) List on November 13, 2024. |
zacks.com |
2024-11-13 09:50:17 |
Czytaj oryginał (ang.) |
| Agilon Health price target lowered to $2 from $5 at Barclays |
Barclays lowered the firm's price target on Agilon Health to $2 from $5 and keeps an Underweight rating on the shares. The company's Q3 results underscore the lack of visibility into real-time trends and limited ability to take control of negative developments, the analyst tells investors in a research note. |
https://thefly.com |
2024-11-11 07:40:22 |
Czytaj oryginał (ang.) |
| agilon health, inc. (AGL) Q3 2024 Earnings Call Transcript |
agilon health, inc. (NYSE:AGL ) Q3 2024 Earnings Call Transcript November 7, 2024 4:30 PM ET Company Participants Leland Thomas - Senior Manager-Investor Relations Steven Sell - Chief Executive Officer Jeffrey Schwaneke - Chief Financial Officer Conference Call Participants Lisa Gill - JPMorgan Justin Lake - Wolfe Research Adam Ron - Bank of America George Hill - Deutsche Bank Sameer Patel - Evercore Ryan Langston - TD Cowen Stephen Baxter - Wells Fargo Andrew Mok - Barclays Jack Slevin - Jefferies Michael Ha - Baird Thomas Keller - RBC Daniel Grosslight - Citi Operator Good afternoon and thank you for joining the agilon health Third Quarter 2024 Earnings Conference Call. |
seekingalpha.com |
2024-11-10 06:58:09 |
Czytaj oryginał (ang.) |
| agilon health Plunges On A Poor Prognosis (Rating Downgrade) |
I initially rated agilon health, inc. as a “hold” due to its volatile financial results and uncertain future, but recent developments necessitate a downgrade to 'sell'. The company's stock plummeted 60.1% since my last article, driven by disappointing Q3 results and reduced guidance, despite revenue growth. Rising medical costs and expansion expenses have severely impacted profitability, with a significant increase in net loss and negative EBITDA. |
seekingalpha.com |
2024-11-08 20:52:16 |
Czytaj oryginał (ang.) |
| Here's What Key Metrics Tell Us About Agilon (AGL) Q3 Earnings |
Although the revenue and EPS for Agilon (AGL) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. |
zacks.com |
2024-11-07 21:00:36 |
Czytaj oryginał (ang.) |
| Agilon Health (AGL) Reports Q3 Loss, Lags Revenue Estimates |
Agilon Health (AGL) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to loss of $0.06 per share a year ago. |
zacks.com |
2024-11-07 20:30:48 |
Czytaj oryginał (ang.) |
| agilon health to Participate at 2024 Wolfe Research Healthcare Conference |
AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the 2024 Wolfe Research Healthcare Conference including a fireside chat presentation on Tuesday, November 19, at 2:20 PM Eastern Time. A simultaneous webcast for the event can be accessed by visiting the “Events & Presentations” section of agilon's Investor Relations website at https://investors.agilonhe. |
businesswire.com |
2024-11-05 18:00:00 |
Czytaj oryginał (ang.) |
| AGILON ALERT: Bragar Eagel & Squire, P.C. is Investigating Agilon Health, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm |
NEW YORK, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Agilon Health, Inc. (NYSE: AGL) on behalf of long-term stockholders following a class action complaint that was filed against Agilon on March 19, 2024 with Class Period (1) Agilon common stock purchases traceable to the April 2021 initial public offering of Agilon stock; (2) pursuant, or traceable, or both, to materials issued in connection with the Company's secondary public offering that occurred on or about May 16, 2023; and/or (3) common stock between April 15, 2021 and February 27, 2024. Our investigation concerns whether the board of directors of Agilon have breached their fiduciary duties to the company. |
globenewswire.com |
2024-10-29 23:00:00 |
Czytaj oryginał (ang.) |
| agilon health Sets Date to Report Third Quarter 2024 Financial Results |
AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the third quarter 2024 after the market closes on Thursday, November 7, 2024, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (404) 975-4839 for international. |
businesswire.com |
2024-10-17 20:00:00 |
Czytaj oryginał (ang.) |
| agilon health: Interesting Business Model, But Volatile And Uncertain |
agilon hagilon healthealth shares dropped significantly after disappointing financial results, down 11.9% in two days. The company's revenue surged 38.7% year over year, but its net loss nearly doubled, and guidance for 2024 is mixed. Concerns include declining cash reserves, potential for further dilution, and uncertainty regarding share valuation. |
seekingalpha.com |
2024-08-16 12:30:00 |
Czytaj oryginał (ang.) |
| AGL Energy Limited (AGLNF) Q4 2024 Earnings Call Transcript |
AGL Energy Limited (OTCPK:AGLNF) Q4 2024 Earnings Conference Call August 13, 2024 9:00 PM ET Company Participants Damien Nicks - Managing Director and Chief Executive Officer Gary Brown - Chief Financial Officer Markus Brokhof - Chief Operating Officer Jo Egan - Chief Customer Officer Conference Call Participants Tom Allen - UBS Anthony Moulder - Jefferies Dale Koenders - Barrenjoey Reinhardt van der Walt - Bank of America Merrill Lynch Mark Busuttil - JPMorgan Ian Myles - Macquarie Gordon Ramsay - RBC Capital Markets Rob Koh - Morgan Stanley Nik Burns - Jarden Australia Henry Meyer - Goldman Sachs Australia Operator Thank you for standing by and welcome to the AGL Energy Full-Year Results Briefing Conference Call. All participants will be in a listen-only mode. |
seekingalpha.com |
2024-08-14 06:17:09 |
Czytaj oryginał (ang.) |
| AGILON ALERT: Bragar Eagel & Squire, P.C. is Investigating Agilon Health, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm |
NEW YORK, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Agilon Health, Inc. (NYSE: AGL) on behalf of long-term stockholders following a class action complaint that was filed against Agilon on March 19, 2024 with Class Period (1) Agilon common stock purchases traceable to the April 2021 initial public offering of Agilon stock; (2) pursuant, or traceable, or both, to materials issued in connection with the Company's secondary public offering that occurred on or about May 16, 2023; and/or (3) common stock between April 15, 2021 and February 27, 2024. Our investigation concerns whether the board of directors of Agilon have breached their fiduciary duties to the company. |
globenewswire.com |
2024-08-09 01:00:00 |
Czytaj oryginał (ang.) |
| Magilon health, inc. (AGL) Q2 2024 Earnings Call Transcript |
Magilon health, inc. (NYSE:AGL ) Q2 2024 Earnings Conference Call August 6, 2024 4:30 PM ET Company Participants Leland Thomas - VP, IR Steven Sell - CEO Jeffrey Schwaneke - CFO Conference Call Participants Lisa Gill - JPMorgan Justin Lake - Wolfe Research Stephen Baxter - Wells Fargo Ryan Daniels - William Blair Elizabeth Anderson - Evercore ISI Adam Ron - Bank of America. |
seekingalpha.com |
2024-08-07 02:20:25 |
Czytaj oryginał (ang.) |
| Agilon (AGL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates |
While the top- and bottom-line numbers for Agilon (AGL) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. |
zacks.com |
2024-08-06 23:36:22 |
Czytaj oryginał (ang.) |
| Agilon Health (AGL) Reports Q2 Loss, Misses Revenue Estimates |
Agilon Health (AGL) came out with a quarterly loss of $0.07 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.04 per share a year ago. |
zacks.com |
2024-08-06 22:21:35 |
Czytaj oryginał (ang.) |